Skip to main content
. 2008 Oct 17;25(9-10):461–466. doi: 10.1007/s10815-008-9262-x

Table 2.

Data of patients treated with rHCG or uHCG

Parameters Group A (rHCG) Group B (uHCG) P value
(n = 42) (n = 47)
Duration of stimulation (d) 11.1 ± 1.2 11.3 ± 1.3 0.56
Total dose of FSH required (IU) 2721 ± 1048 2872 ± 1057 0.5
Estradiol on day of HCG administration (pg/mL) 1709 ± 848 1691 ± 773 0.92
Follicles day HCG 10.2 ± 5.1 8.8 ± 5 0.19
Retrived oocytes 8.4 ± 5 7.1 ± 5.2 0.23
Metaphase II oocytes (MII) 7.4 ± 4.6 5.7 ± 3.8 0.06
% MII oocytes 88.1% (312/354) 81.8% (270/334) <0.01*
MII oocytes with mature cytoplasm 7.3 ± 4.2 4.7 ± 3.1 <0.01*
%MII with mature cytoplasm calculated from total MII oocytes 89.1% (278/312) 81.8% (221/270) <0.01*
Fertilization rate 87.2% 86.7% 0.99
Injected oocytes 7.1 ± 4.3 5.5 ± 3.5 0.06
% Top quality embryo (grade A) 34% (65/191) 40.4% (75/210) 0.8
Transferred embryos 2.7 ± 0.9 2.9 ± 1.0 0.23
B-hCG positive (%) 50%(21/42) 51% (24/47) 0.92
Implantation rate 23% 21.2% 0.81
Abortion rate 19% 20.8% 0.88

Parameters expressed as mean ± SD or percentages, as appropriate.